EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Isolation, Characterization, and Anti-Idiopathic Pulmonary Fibrosis Activity of a Fucoidan from Costaria costata

Sijie Wei iD, Lihua Geng, Haoyu Yu, Jing Wang, Yang Yue iD, Quanbin Zhang, Ning Wu

Molecules · 2023

DOI: 10.3390/molecules28114343 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Sijie Wei und 6 weiteren Autor:innen. Beteiligte Einrichtung: CAS and Shandong Province Key Laboratory of Experimental Marine Biology, Center for Ocean Mega-Science, Institute of Oceanology, Chinese Academy of S…. Hauptthemen laut MEDLINE: Phosphatidylinositol 3-Kinases, Idiopathic Pulmonary Fibrosis. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, Nantong Science and Technology Bureau, National Key R&D Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pulmonary fibrosis is a chronic, progressive, and fatal disease of the interstitial lung. There is currently a lack of efficient therapy to reverse the prognosis of patients. In this study, a fucoidan from Costaria costata was isolated, and its anti-idiopathic fibrosis activity was investigated both in vitro and in vivo. The chemical composition analysis showed that C. costata polysaccharide (CCP) consists of galactose and fucose as the main monosaccharides with a sulfate group content of 18.54%. Further study found that CCP could resist TGF-β1-induced epithelial-mesenchymal transition (EMT) in A549 cells by inhibiting the TGF-β/Smad and PI3K/AKT/mTOR signaling pathways. Moreover, in vivo study found that CCP treatment alleviated bleomycin (BLM)-stimulated fibrosis and inflammation in mice lung tissue. In conclusion, the present study suggests that CCP could protect the lung from fibrosis by relieving the EMT process and inflammation in lung cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Phosphatidylinositol 3-KinasesIdiopathic Pulmonary FibrosisMiceAnimalsLungTransforming Growth Factor beta1PolysaccharidesFibrosisEpithelial-Mesenchymal TransitionInflammationBleomycin

Stichwörter der Autor:innen

Costaria costatafucoidanidiopathic pulmonary fibrosis

Substanzen

fucoidanPhosphatidylinositol 3-KinasesTransforming Growth Factor beta1PolysaccharidesBleomycin

Autor:innen und Institutionen

  • CAS and Shandong Province Key Laboratory of Experimental Marine Biology, Center for Ocean Mega-Science, Institute of Oceanology, Chinese Academy of Sciences, Qingdao 266071, China.
  • University of Chinese Academy of Sciences, Beijing 101408, China.
  • Drugs and Bioproducts, Qingdao National Laboratory for Marine Science and Technology, Qingdao 266237, China.
  • Nantong Zhongke Marine Science and Technology Research and Development Center, Nantong 226682, China.

ORCID-Profile: Sijie Wei, Yang Yue

Förderung

  • National Key R&D Program of China
  • Nantong Science and Technology Bureau
  • National Key R&D Program of China
  • Nantong Science and Technology project

Zitieren

APA

Wei, S., Geng, L., Yu, H., Wang, J., Yue, Y., Zhang, Q., & Wu, N. (2023). Isolation, Characterization, and Anti-Idiopathic Pulmonary Fibrosis Activity of a Fucoidan from Costaria costata. Molecules. https://doi.org/10.3390/molecules28114343

Vancouver

Wei S, Geng L, Yu H, Wang J, Yue Y, Zhang Q, et al. Isolation, Characterization, and Anti-Idiopathic Pulmonary Fibrosis Activity of a Fucoidan from Costaria costata. Molecules. 2023. doi:10.3390/molecules28114343

BibTeX
@article{Wei2023,
  author = {Wei, Sijie and Geng, Lihua and Yu, Haoyu and Wang, Jing and Yue, Yang and Zhang, Quanbin and Wu, Ning},
  title = {Isolation, Characterization, and Anti-Idiopathic Pulmonary Fibrosis Activity of a Fucoidan from Costaria costata},
  journal = {Molecules},
  year = {2023},
  doi = {10.3390/molecules28114343}
}
Kostenlos starten →